Healthcare >> CEO Interviews >> February 25, 2002
MARVIN P. LOEB is Chairman and Chief Executive Officer of Trimedyne,
Inc. He is a respected entrepreneur, inventor and businessman in the
healthcare field. He founded 28 ventures over the last 30 years and took
13 of them public by IPO, of which 12 have been sold to or merged with
larger companies. Six of the privately held companies were sold for
stock to public companies without going through an IPO, and two were
sold for cash. Four of the companies failed, and three are still
privately held. Prior to becoming an entrepreneur, Mr. Loeb formed and
managed his own chemical/food products company for 14 years before
selling it to Consolidated Foods Corporation (now Sara Lee), and he
gained substantial insight into the workings of the stock market as a
private investor and as a part owner of two broker/dealer firms. Most of
the ventures he created and stewarded through their formative years were
devoted to the development of medical devices used in less invasive or
totally new procedures, as well as new drugs and biologics. Mr. Loeb
received an honorary Doctor of Science degree from Pacific States
University, and he earned a BS degree in Chemistry and Mathematics from
the University of Illinois in Urbana. His scientific talents and many
years of business experience have given him the unique ability to
recognize viable medical innovations, estimate their market potential
and evaluate their merits, compared to existing or developing
technologies. Profile
overview of what the company is doing at the present time?
Mr. Loeb: Trimedyne manufactures lasers for use in the medical
